Literature DB >> 16010968

Role of atrial natriuretic peptide in the suppression of lysophosphatydic acid-induced rat aortic smooth muscle (RASM) cell growth.

P M Baldini1, P De Vito, F D'aquilio, D Vismara, F Zalfa, C Bagni, R Fiaccavento, P Di Nardo.   

Abstract

Lysophosphatidic acid (LPA) is a lipid mediator with multiple biological functions. In the present study we investigated the possible role of atrial natriuretic peptide (ANP), a hormone affecting cardiovascular homeostasis and inducing antimitogenic effects in different cell types, on LPA-induced cell growth and reactive oxygen species (ROS) production in rat aortic smooth muscle (RASM) cells. Both LPA effects on cell growth and levels of ROS were totally abrogated by physiological concentrations of ANP, without modifying the overexpression of LPA-receptors. These effects were also affected by cell pretreatment with wortmannin, an inhibitor of phosphatidylinositol 3-kinase (PI3K). Moreover, the LPA-induced activation of Akt, a downstream target of PI3K, was completely inhibited by physiological concentrations of ANP, which were also able to inhibit p42/p44 phosphorylation. Taken together, our data suggest that PI3K may represent an important step in the LPA signal transduction pathway responsible for ROS generation and DNA synthesis in RASM cells. At same time, the enzyme could also represent an essential target for the antiproliferative effects of ANP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16010968     DOI: 10.1007/s11010-005-4779-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  40 in total

Review 1.  Natriuretic peptide signalling: molecular and cellular pathways to growth regulation.

Authors:  M Silberbach; C T Roberts
Journal:  Cell Signal       Date:  2001-04       Impact factor: 4.315

Review 2.  Physiology and pathophysiology of sphingolipid metabolism and signaling.

Authors:  A Huwiler; T Kolter; J Pfeilschifter; K Sandhoff
Journal:  Biochim Biophys Acta       Date:  2000-05-31

Review 3.  The role of PI3K in immune cells.

Authors:  Shigeo Koyasu
Journal:  Nat Immunol       Date:  2003-04       Impact factor: 25.606

Review 4.  Lysophosphatidic acid, a multifunctional phospholipid messenger.

Authors:  W H Moolenaar
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

Review 5.  Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator.

Authors:  K Jalink; P L Hordijk; W H Moolenaar
Journal:  Biochim Biophys Acta       Date:  1994-12-30

6.  Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts.

Authors:  L Cao; D G Gardner
Journal:  Hypertension       Date:  1995-02       Impact factor: 10.190

7.  Lysophosphatidic acid and platelet-derived growth factor synergistically stimulate growth of cultured rat mesangial cells.

Authors:  C N Inoue; Y H Ko; W B Guggino; H G Forster; M Epstein
Journal:  Proc Soc Exp Biol Med       Date:  1997-12

8.  Clearance receptor-binding atrial natriuretic peptides inhibit mitogenesis and proliferation of rat aortic smooth muscle cells.

Authors:  P A Cahill; A Hassid
Journal:  Biochem Biophys Res Commun       Date:  1991-09-30       Impact factor: 3.575

Review 9.  Phosphoinositide 3-kinases in lysophosphatidic acid signaling: regulation and cross-talk with the Ras/mitogen-activated protein kinase pathway.

Authors:  Armelle Yart; Hugues Chap; Patrick Raynal
Journal:  Biochim Biophys Acta       Date:  2002-05-23

10.  Participation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogen-activated protein kinase kinase activation pathway.

Authors:  Q Chen; N Olashaw; J Wu
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

View more
  8 in total

1.  Lysophosphatidic acid effects on atherosclerosis and thrombosis.

Authors:  Mei-Zhen Cui
Journal:  Clin Lipidol       Date:  2011-08

2.  Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury.

Authors:  Yoshihisa Ogawa; Masashi Mukoyama; Hideki Yokoi; Masato Kasahara; Kiyoshi Mori; Yukiko Kato; Takashige Kuwabara; Hirotaka Imamaki; Tomoko Kawanishi; Kenichi Koga; Akira Ishii; Takeshi Tokudome; Ichiro Kishimoto; Akira Sugawara; Kazuwa Nakao
Journal:  J Am Soc Nephrol       Date:  2012-05-31       Impact factor: 10.121

3.  Activatory properties of lysophosphatidic acid on human THP-1 cells.

Authors:  F D'Aquilio; M Procaccini; V Izzi; V Chiurchiu'; V Giambra; F Carotenuto; P Di Nardo; P M Baldini
Journal:  Inflammation       Date:  2006-11-07       Impact factor: 4.092

4.  Activatory properties of lysophosphatidic acid on human THP-1 cells.

Authors:  F D'Aquilio; M Procaccini; V Izzi; V Chiurchiu'; V Giambra; F Carotenuto; P Di Nardo; P M Baldini
Journal:  Inflammation       Date:  2007-10       Impact factor: 4.092

5.  NPRA-mediated suppression of AngII-induced ROS production contribute to the antiproliferative effects of B-type natriuretic peptide in VSMC.

Authors:  Pan Gao; De-Hui Qian; Wei Li; Lan Huang
Journal:  Mol Cell Biochem       Date:  2008-12-23       Impact factor: 3.396

Review 6.  Lysophosphatidic acid in atherosclerotic diseases.

Authors:  Andreas Schober; Wolfgang Siess
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

7.  Chronic treatment with atrial natriuretic peptide in spontaneously hypertensive rats: beneficial renal effects and sex differences.

Authors:  Mariana Romero; Carolina Caniffi; Gonzalo Bouchet; María A Costa; Rosana Elesgaray; Cristina Arranz; Analía L Tomat
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

Review 8.  Signaling pathways involved in renal oxidative injury: role of the vasoactive peptides and the renal dopaminergic system.

Authors:  N L Rukavina Mikusic; M C Kravetz; N M Kouyoumdzian; S L Della Penna; M I Rosón; B E Fernández; M R Choi
Journal:  J Signal Transduct       Date:  2014-11-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.